XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Awards Granted

The following table summarizes the Company’s stock awards granted for each of the periods indicated:

 

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

Grants

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Grants

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Grants

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Grants

 

 

Weighted
Average
Grant
Date Fair
Value

 

Stock options

 

 

127,100

 

 

$

59.84

 

 

 

91,200

 

 

$

42.62

 

 

 

1,626,220

 

 

$

47.54

 

 

 

1,522,947

 

 

$

48.50

 

Restricted stock units*

 

 

65,657

 

 

$

105.28

 

 

 

47,594

 

 

$

83.37

 

 

 

925,167

 

 

$

80.66

 

 

 

774,201

 

 

$

86.34

 

Summary of Stock-Based Compensation Expense by Function Included within Condensed Consolidated Statements of Operations and Comprehensive Loss The following table summarizes stock-based compensation expense by function included within the unaudited condensed consolidated statements of operations and comprehensive loss:

 

 

 

For the Three Months Ended
September 30,

 

 

For the Nine Months Ended
September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

(in thousands)

 

Research and development

 

$

14,795

 

 

$

12,031

 

 

$

42,330

 

 

$

36,017

 

Selling, general and administrative

 

 

35,623

 

 

 

14,653

 

 

 

140,178

 

 

 

48,144

 

Total stock-based compensation expense

 

$

50,418

 

 

$

26,684

 

 

$

182,508

 

 

$

84,161

 

Summary of Stock-Based Compensation Expense by Grant Type Included within Consolidated Statements of Operations and Comprehensive Loss

The following table summarizes stock-based compensation expense by grant type included within the unaudited condensed consolidated statements of operations and comprehensive loss:

 

 

 

For the Three Months Ended
September 30,

 

 

For the Nine Months Ended
September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

(in thousands)

 

Stock options

 

$

35,686

 

 

$

13,912

 

 

$

141,247

 

 

$

48,518

 

Restricted stock awards/units

 

 

13,321

 

 

 

11,695

 

 

 

37,064

 

 

 

32,199

 

Employee stock purchase plan

 

 

1,411

 

 

 

1,077

 

 

 

4,197

 

 

 

3,444

 

Total stock-based compensation expense

 

$

50,418

 

 

$

26,684

 

 

$

182,508

 

 

$

84,161